Tech giants urge Congress to block AI-assisted bioweapon threats
A rare coalition of industry rivals has petitioned US lawmakers to mandate rigorous screening of synthetic DNA and RNA orders. Signatories argue that current gaps in biosecurity oversight allow sophisticated AI models to lower the barrier for bad actors seeking to design and manufacture dangerous, engineered pathogens.
The open letter features leadership from Anthropic, OpenAI, Microsoft, and Google DeepMind, marking a unified front on the risks posed by synthetic biology. These executives, including Sam Altman and Nobel laureate Demis Hassabis, warn that AI tools now simplify the complex process of creating genetic sequences that previously required deep specialized expertise. By requiring companies that sell synthetic material to vet orders against known dangerous pathogens, the group aims to prevent the accidental or malicious release of engineered threats.
This initiative follows long-standing warnings from the scientific community regarding the potential for synthetic biology to resurrect extinct pathogens or create entirely new biological hazards. The letter, coordinated by the Foundation for American Innovation and the Institute for Progress, draws support from biotech firms like Twist Bioscience, signaling a move toward industry-wide compliance standards to mitigate pandemic risks.
Comments (0)
No comments yet. Be the first!